L-carnitine shuttles long-chain fatty acids into mitochondria, the part of the cell that makes ATP (usable energy)
Townsend 3,256 views October 7, 2024 20 Caroline Apovian Weight Loss and Pharmacologic Management of Obesity in 2024 1,853 views October 28, 2024 20 John La Puma The GLP-1 Playbook and Essence 1,539 views April 11, 2025 18 Brian Wojeck Update on Obesity Pharmacotherapy 1,595 views December 23, 2024 18 Scripps Health Primary Care Literature Update: 2022/2023 FEATURING Joel Diamant 1,061 views September 12, 2023 18 Holly Wyatt Myths of Obesity Care: Health at Almost Every Size
Not in a flashy, trend-of-the-moment way, but in a deeper people are truly eating differently kind of way
Zinc is not part of ceruloplasmin
Hexarelin does this through a calcium/PKC cascade while blunting somatostatin's inhibitory signal, and Ipamorelin is considered more selective because it does not meaningfully raise cortisol or prolactin alongside GH
Already in effect (January 1, 2026): Standard PA decisions within 7 calendar days (down from 14) Urgent PA decisions within 72 hours Specific denial reasons required on every denial (not just not medically necessary) Applies to Medicare Advantage, Medicaid managed care, CHIP, and ACA Marketplace plans Coming March 31, 2026: Payers must publicly report PA metrics for calendar year 2025: approval/denial rates, average decision times, and appeals outcomes Providers will be able to compare payer performance for the first time Coming January 1, 2027: FHIR-based Prior Authorization APIs required providers check PA requirements, submit requests, and receive decisions electronically through their EHR Expected to reduce average PA processing time from days to minutes for standard requests Medicare WISeR Model (live in AZ and WA): The Wasteful and Inappropriate Services Reduction pilot launched January 2026 in six states including Arizona and Washington
/assets/images/provider/photos/1922393.jpg)
